Changes coming to U.S. import regulations, effective August 29th, 2025. All shipments may be affected. Read more for continued updates.
(Rivaroxaban)
Prescription required. Can not be split. Product of Germany. Shipped from Australia.
Prescription required. Can not be split. Product of India. Shipped from Mauritius.
Prescription required. Can not be split. Product of Germany. Shipped from Australia.
Prescription required. Can not be split. Product of UK/EU. Shipped from United Kingdom.
Prescription required. Can not be split. Product of New Zealand. Shipped from New Zealand.
Prescription required. Can not be split. Product of India. Shipped from Mauritius.
Prescription required. Can not be split. Product of UK/EU. Shipped from United Kingdom. Xarelto is also marketed internationally under the name Xarelto Treatment Initiation Pack.
Prescription required. Can not be split. Product of New Zealand. Shipped from Mauritius.
Prescription required. Can not be split. Product of India. Shipped from Mauritius.
Xarelto (rivaroxaban) is a prescription anticoagulant (blood thinner) used to prevent and treat blood clots. It works by inhibiting Factor Xa, a key enzyme in the blood-clotting process. Xarelto is available as oral tablets and a liquid suspension for pediatric use. It is commonly prescribed to lower the risk of stroke, deep vein thrombosis (DVT), pulmonary embolism (PE), and other clot-related conditions.
Xarelto is used for the following:
Preventing stroke and blood clots in people with non-valvular atrial fibrillation
Preventing blood clots after hip or knee replacement surgery
Treating DVT (blood clots in areas of the body like the legs) and PE (blood clots in the lungs), and preventing recurrence
Reducing the risk of heart attack and stroke in people with coronary artery disease (CAD)
Reducing the risk of a loss of blood flow to limbs, amputation, and stroke in peripheral artery disease (PAD)
Treating and preventing clots in children, including after the Fontan procedure for congenital heart disease
To comply with Canadian International Pharmacy Association regulations you are permitted to order a 3-month supply or the closest package size available based on your personal prescription. read more
Dosage varies by indication. Common tablet strengths include 2.5 mg, 10 mg, 15 mg, and 20 mg.
Adults:
Take 15 mg or 20 mg tablets with food to improve absorption.
Take 2.5 mg or 10 mg tablets with or without food.
Pediatric oral suspension dosing is weight-based; use only the provided syringe to measure the dose to ensure accuracy.
Pediatric patients are encouraged to take Xarelto with food to help promote absorption and ensure the medication is effective.
Do not split tablets. If necessary, tablets may be crushed and taken with applesauce or through a feeding tube (consult your provider).
Before using Xarelto, inform your healthcare provider if you:
Have a history of bleeding problems
Have kidney or liver issues
Have a prosthetic heart valve
Have a history of antiphospholipid syndrome
Are pregnant, plan to become pregnant, or are breastfeeding
Are taking other medications or supplements (especially blood thinners, NSAIDs, SSRIs/SNRIs)
Do not take Xarelto if:
You are allergic to rivaroxaban or its ingredients
You have active bleeding
Do not stop taking Xarelto without medical advice — stopping suddenly may increase the risk of dangerous blood clots.
Avoid grapefruit and grapefruit juice — it may raise the level of Xarelto in your blood and increase bleeding risk.
Limit alcohol intake, as alcohol and Xarelto both increase bleeding risk.
If a dose is missed, take it as soon as you remember on the same day.
If taking twice daily (e.g., 15 mg), taking two tablets together to make up for a missed dose may be recommended. This recommendation is more likely if an established clot is being treated.
Do not double the next dose unless specifically instructed.
Contact your provider for guidance based on your indication and dosage.
Because Xarelto slows down the formation of blood clots, there is an increased risk of bleeding. In some instances, bleeding may become serious or life-threatening.
Bleeding (e.g., nosebleeds, bruising)
Abdominal pain
Fatigue
Muscle spasms
Dizziness
Mood changes
Cough, vomiting, or gastrointestinal inflammation (especially in children)
Seek immediate help if you experience:
Signs of severe bleeding (e.g., red/black stools, vomiting blood, blood in urine)
Allergic reactions (e.g., swelling of the face/lips/throat, rash, difficulty breathing)
Dizziness, fainting, or rapid heartbeat
Coughing up blood or blood clots
Report adverse effects to the FDA (1-800-FDA-1088) or Health Canada (1-866-234-2345).
Store at 68°F to 77°F (20°C to 25°C); short-term exposure to 59°F–86°F (15°C–30°C) is acceptable.
Keep in a cool, dry place away from children.
Do not freeze the oral suspension. Discard unused liquid after the “Discard after” date on the bottle.
Always use the provided measuring syringe for the oral liquid — household spoons are inaccurate.
People aged 65 and older may have a higher risk of bleeding; discuss safety with your provider. Bleeding associated with injuries due to falls can be particularly dangerous.
For overdose: call Poison Control at 1-800-222-1222 in the US or 1-844-764-7669 in Canada, or seek emergency care.
For more information, visit the manufacturer’s website at www.xarelto-us.com or call 888-XARELTO.
The content on this page is for informational and educational purposes only and does not constitute professional medical advice. Patients should not use the information presented on this page for diagnosing a health-related issue or disease. Before taking any medication or supplements, patients should always consult a physician or qualified healthcare professional for medical advice or information about whether a drug is safe, appropriate or effective.
